Physician Tool for Patient Discussion: Learning to Identify and Actively report Adverse Events with Lorlatinib

Physician Tool for Patient Discussion: Learning to Identify and Actively report Adverse Events with Lorlatinib

Available in English and French
Physician Tool for Patient DiscussionTop Web banner

Easy to understand graphics will help to facilitate discussion between patients and their oncology healthcare team to manage adverse events.

Download this Physician Tool for Patient Discussion to empower patients and their caregivers to identify and actively report ALK TKI-related adverse events.

Supported by unrestricted educational funding from Pfizer.